Experimental sepsis using Pseudomonas aeruginosa: The significance of multi-drug resistance

International Journal of Antimicrobial Agents

Volumn 24, Issue 4, 2004, Pages 357-361

  Giamarellos Bourboulis, Evangelos J ^a   Koussoulas, Vassilios ^a   Panagou, Charalambos ^a   Adamis, Theodoros ^a   Baziaka, Fotini ^a   Skiadas, Ioannis ^a   Perrea, Despina ^a   Dionyssiou Asteriou, Amalia ^a   Giamarellou, Helen ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Lipid peroxidation; Multidrug resistance; Pseudomonas aeruginosa; Sepsis

Indexed keywords

AMIKACIN; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; MALONALDEHYDE; MEROPENEM; PIPERACILLIN; TIMENTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL SURVIVAL; BACTERIUM ISOLATE; BLOOD CELL COUNT; BLOOD SAMPLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; INFECTION SENSITIVITY; INTRAVENOUS CATHETER; JUGULAR VEIN; LIVER; LUNG LOBE; MALE; MESENTERY LYMPH NODE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPSIS; SPLEEN; STATISTICAL SIGNIFICANCE; TISSUE LEVEL;

ANIMALS; ANTI-BACTERIAL AGENTS; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; HUMANS; LIVER; LUNG; LYMPH NODES; MALE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RABBITS; SEPSIS; SPLEEN;

EID: 5644280315     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.03.025     Document Type: Article

References (10)

1. Giamarellos-Bourboulis E.J., Plachouras D., Tzivra A., et al. Stimulation of innate immunity by susceptible and multidrug-resistant Pseudomonas aeruginosa. Clin Exp Immunol. 135:2004;240-246
2. Glauser M.P., Zanetti G., Baumgartner J.D., Cohen J. Septic shock: pathogenesis. Lancet. 338:1991;732-736
3. Hirakata Y., Srikumar R., Poole K., et al. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J Exp Med. 196:2002;109-118
4. Giamarellos-Bourboulis E.J., Grecka P., Dionyssiou-Asteriou A., Giamarellou H. In vitro activity of polyunsaturated fatty acids on Pseudomonas aeruginosa: relationship to lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids. 58:1998;283-287
5. Muzio G., Salvo R.A., Trombetta A., et al. Dose-dependent inhibition of cell proliferation induced by lipid peroxidation products in rat hepatoma cells after enrichment with arachidonic acid. Lipids. 34:1999;705-711
6. Engelhard D., Pomernz S., Gallily S., Strauss N., Tuomanen E. Serotype-related differences in inflammatory response to Streptococcus pneumoniae in experimental meningitis. J Infect Dis. 175:1997;979-982
7. Gales A.C., Jones R.N., Turnidge J., Rennie R., Ramphal R. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY antimicrobial surveillance program, 1997-1999. Clin Infect Dis. 32:2001;S146-S155
8. Tacconelli E., Tumbarello M., Bertagnolio S., et al. Multidrug-resistant Pseudomonas aeruginosa bloodstream infection: analysis of trends in prevalence and epidemiology. Emerg Infect Dis. 8:2002;220-221
9. Goode H.F., Cowley H.C., Walker B.E., Howdle P.D., Webster N.R. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med. 23:1995;646-651
10. Giamarellos-Bourboulis E.J., Skiathitis S., Dionyssiou-Asteriou A., et al. Lipid peroxidation by Pseudomonas aeruginosa in the pathogenesis of nosocomial sepsis. J Postgrad Med. 49:2003;118-122